Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate

Mostrar otras versiones (1)

Zuclopenthixol is usually used in parental form to manage acute agitation and psychosis.[1] It has high affinity for dopamine D1 and D2 receptors. There are very few reports of Neuroleptic Malignant Syndrome (NMS) with use of zuclopenthixol monotherapy. In this case report, we present a 35 year old...

Descripción completa

Detalles Bibliográficos
Autores principales: Shouan, Anish, Sinha, Ankit Kumar, Grover, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188941/
https://www.ncbi.nlm.nih.gov/pubmed/34158726
http://dx.doi.org/10.4103/ipj.ipj_49_19

Ejemplares similares

Ejemplares similares